BRPI0406470A - Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação - Google Patents

Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação

Info

Publication number
BRPI0406470A
BRPI0406470A BR0406470-4A BRPI0406470A BRPI0406470A BR PI0406470 A BRPI0406470 A BR PI0406470A BR PI0406470 A BRPI0406470 A BR PI0406470A BR PI0406470 A BRPI0406470 A BR PI0406470A
Authority
BR
Brazil
Prior art keywords
homogenate
polypeptide
broth
purification
heterologous polypeptide
Prior art date
Application number
BR0406470-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Philip M Lester
Josefine Persson
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BRPI0406470A publication Critical patent/BRPI0406470A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR0406470-4A 2003-01-09 2004-01-08 Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação BRPI0406470A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43941803P 2003-01-09 2003-01-09
PCT/US2004/000499 WO2004092393A1 (en) 2003-01-09 2004-01-08 Purification of polypeptides

Publications (1)

Publication Number Publication Date
BRPI0406470A true BRPI0406470A (pt) 2005-12-06

Family

ID=33299572

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406470-4A BRPI0406470A (pt) 2003-01-09 2004-01-08 Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação

Country Status (18)

Country Link
US (2) US7169908B2 (enExample)
EP (1) EP1581644B1 (enExample)
JP (1) JP2006517415A (enExample)
KR (1) KR20050095605A (enExample)
CN (1) CN100467611C (enExample)
AT (1) ATE364092T1 (enExample)
AU (1) AU2004230670B2 (enExample)
BR (1) BRPI0406470A (enExample)
CA (1) CA2511946A1 (enExample)
DE (1) DE602004006831T2 (enExample)
DK (1) DK1581644T3 (enExample)
ES (1) ES2287687T3 (enExample)
MX (1) MXPA05007378A (enExample)
NZ (1) NZ540895A (enExample)
PL (1) PL377653A1 (enExample)
RU (1) RU2337968C2 (enExample)
WO (1) WO2004092393A1 (enExample)
ZA (1) ZA200504990B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
HUE027196T2 (hu) * 2002-09-06 2016-10-28 Genentech Inc Eljárás fehérjeextrakcióra
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
NZ562292A (en) 2005-04-11 2009-11-27 Savient Pharmaceuticals Inc Variant forms of urate oxidase and use thereof
EP1973942B1 (en) 2005-12-22 2011-02-09 Genentech, Inc. Recombinant production of heparin binding proteins
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
NZ573639A (en) 2006-07-14 2012-03-30 Genentech Inc Refolding of recombinant proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
WO2008079302A2 (en) 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
DK2104739T3 (da) * 2006-12-21 2013-10-07 Novozymes Inc Modificerede messenger-RNA-stabiliseringssekvenser til ekspression af gener i bakterieceller
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
AU2008209404B2 (en) * 2007-01-22 2012-08-16 Genentech, Inc. Polyelectrolyte precipitation and purification of antibodies
PL2188302T3 (pl) 2007-07-09 2018-04-30 Genentech, Inc. Zapobieganie redukcji wiązań disiarczkowych podczas rekombinacyjnego wytwarzania polipeptydów
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
WO2009151514A1 (en) 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
EP2337787A1 (en) * 2008-10-17 2011-06-29 Percivia LLC. Clarification process
US20100190963A1 (en) 2008-12-16 2010-07-29 Millipore Corporation Stirred Tank Reactor And Method
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
KR101858598B1 (ko) * 2010-02-01 2018-05-16 디그나 비오테크, 에스.엘. 인터페론 알파 5의 제조방법
ES2395093T3 (es) * 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos
EP2545066B1 (en) * 2010-03-10 2017-09-20 F. Hoffmann-La Roche AG Method for purifying immunoglobulin solutions
JO3131B1 (ar) 2010-04-27 2017-09-20 Glaxosmithkline Llc مركبات كيميائية
EP2571903B1 (en) 2010-05-17 2019-09-04 EMD Millipore Corporation Stimulus responsive polymers for the purification of biomolecules
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
DE102011001743A1 (de) * 2011-04-01 2012-10-04 Technische Universität Dortmund Verfahren zur Trennung/Reinigung von Biomolekühlen
KR102492792B1 (ko) 2011-10-11 2023-01-30 제넨테크, 인크. 이중특이적 항체의 개선된 어셈블리
CN102443055B (zh) * 2011-10-26 2017-07-28 浙江海正药业股份有限公司 一种重组人肿瘤坏死因子相关凋亡诱导配体的纯化工艺
WO2013180648A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
CN102701501A (zh) * 2012-06-26 2012-10-03 天津市津华盛生物科技有限公司 工业乳酸链球菌素废水综合利用的方法
CN105026418B (zh) * 2013-02-06 2019-01-11 新加坡科技研究局 蛋白质纯化方法
EP2961759A4 (en) 2013-02-26 2016-09-28 Agency Science Tech & Res PROTEIN CLEANING IN THE PRESENCE OF NON-ORGANIC POLYMERS AND ELECTROPOSITIVE SURFACES
CN105189530B (zh) * 2013-02-28 2019-06-07 新加坡科技研究局 从缺乏染色质的细胞培养收获物中色谱纯化抗体
WO2014133460A1 (en) * 2013-02-28 2014-09-04 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers at elevated conductivity
EP2992021B1 (en) * 2013-04-30 2020-07-22 Intas Pharmaceuticals Limited Novel cloning, expression & purification method for the preparation of ranibizumab
RU2687153C2 (ru) * 2014-04-30 2019-05-07 Новозимс А/С Способ снижения содержания днк в ферментационном бульоне
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
CN108333263A (zh) * 2017-01-20 2018-07-27 北京蛋白质组研究中心 一种尿蛋白制备方法及尿蛋白质组的检测方法
TW201927335A (zh) * 2017-10-02 2019-07-16 美商拜耳保健有限責任公司 防止雙硫鍵於細胞培養收集物中還原之方法
BR112020010615A2 (pt) * 2017-12-22 2020-10-27 Regeneron Pharmaceuticals, Inc. produto farmacêutico proteico, método e sistema para caracterizar impurezas de produto farmacêutico proteico e de fármaco de baixo peso molecular, método para produzir um anticorpo, anticorpo, e, usos do método e do sistema
CN111363024A (zh) * 2018-12-26 2020-07-03 深圳翰宇药业股份有限公司 多肽的纯化方法
WO2020247983A1 (en) * 2019-06-05 2020-12-10 Viome, Inc. Sample collection methods and devices
EP4136211B1 (en) 2020-04-15 2025-07-09 Genentech, Inc. Copper loss mitigation
CN112708566A (zh) * 2021-01-25 2021-04-27 西南林业大学 一种黑曲霉生产胞外多聚物的优化培养基及培养方法
CN114774500A (zh) * 2022-04-26 2022-07-22 成都蜀星饲料有限公司 多肽及制备方法、有机复合微量元素及制备方法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
US3903254A (en) * 1971-07-23 1975-09-02 Upjohn Co Separation of erythrocyte stroma from lysing medium and hemoglobin with acrinol
DE2308013A1 (de) * 1973-02-17 1974-09-12 Behringwerke Ag Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung
JPS519035B2 (enExample) 1973-10-31 1976-03-23
SU944580A1 (ru) 1980-02-07 1982-07-23 Кировский научно-исследовательский институт переливания крови Способ получени поверхностного антигена гепатита В
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
WO1986007093A1 (fr) * 1985-05-29 1986-12-04 The Green Cross Corporation Procede de preparation d'une proteine heterogene
WO1987000553A1 (fr) * 1985-07-16 1987-01-29 The Green Cross Corporation Procede de preparation d'hetero-proteine
DE3604947A1 (de) 1986-02-17 1987-08-20 Biotest Pharma Gmbh Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids
FR2600078B1 (fr) 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
DE4030264A1 (de) * 1990-09-25 1992-04-23 Hoechst Ag Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5861263A (en) * 1992-10-20 1999-01-19 Universidad Autonoma De Nuevo Leon Preparation of preserved entamoeba histolytica antigens without enzymatic inhibitors and their use in immunological methods
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5760189A (en) 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DK0998486T4 (da) 1997-06-13 2012-05-14 Genentech Inc Proteinoprensning ved kromatografi efterfulgt af filtrering på en ladet fase
JPH11341947A (ja) * 1998-06-02 1999-12-14 Yakult Honsha Co Ltd 発酵管理方法
US6156514A (en) * 1998-12-03 2000-12-05 Sunol Molecular Corporation Methods for making recombinant cells
AU2001231016A1 (en) * 2000-01-20 2001-07-31 Regents Of The University Of Minnesota Peptides with antibacterial activity

Also Published As

Publication number Publication date
US7169908B2 (en) 2007-01-30
AU2004230670B2 (en) 2010-11-25
ATE364092T1 (de) 2007-06-15
EP1581644B1 (en) 2007-06-06
DK1581644T3 (da) 2007-10-08
NZ540895A (en) 2007-03-30
DE602004006831D1 (de) 2007-07-19
EP1581644A1 (en) 2005-10-05
US20070077625A1 (en) 2007-04-05
DE602004006831T2 (de) 2008-02-14
ZA200504990B (en) 2006-08-30
JP2006517415A (ja) 2006-07-27
CN1759186A (zh) 2006-04-12
RU2005125210A (ru) 2006-01-10
CA2511946A1 (en) 2004-10-28
PL377653A1 (pl) 2006-02-06
MXPA05007378A (es) 2005-11-23
US20050037456A1 (en) 2005-02-17
RU2337968C2 (ru) 2008-11-10
AU2004230670A1 (en) 2004-10-28
ES2287687T3 (es) 2007-12-16
KR20050095605A (ko) 2005-09-29
CN100467611C (zh) 2009-03-11
WO2004092393A1 (en) 2004-10-28
US7579448B2 (en) 2009-08-25

Similar Documents

Publication Publication Date Title
BRPI0406470A (pt) Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação
Chi et al. Influence of amino acid compositions and peptide profiles on antioxidant capacities of two protein hydrolysates from skipjack tuna (Katsuwonus pelamis) dark muscle
Pivokonsky et al. Evaluation of the production, composition and aluminum and iron complexation of algogenic organic matter
ATE334218T1 (de) Verfahren zur gleichzeitigen herstellung von xylitol und ethanol
US20060241287A1 (en) Extracting biopolymers from a biomass using ionic liquids
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
ATE536859T1 (de) Maca-extrakt und diesen extrakt enthaltende kosmetische zusammensetzung
BR0203040A (pt) Processo para preparação de um ácido silìcico de precipitação hidrófobo com elevado grau de brancura e absorção de umidade extremamente baixa
DE602004025265D1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
ATE319700T1 (de) Verfahren zu herstellung von tocotrienolen
Piazza et al. Identification of highly active flocculant proteins in bovine blood
Bułkowska et al. Recovery of Biogas and Other Valuable Bioproducts from Livestock Blood Waste: A Review
BR0316782A (pt) Produto de leite fermentado, processo para preparação de um produto de leite fermentado e uso da linhagem cnrz 244 de lactobacillus helveticus
Sisa et al. Valorization of yellowfin tuna tails: From proteolytic enzyme production to gelatin and antioxidant hydrolysate extraction
Nakamura et al. Changes in properties of the inner mitochondrial membrane during mitochondrial biogenesis in aging sweet potato tissue slices in relation to the development of cyanide-insensitive respiration
Yusuf The utilization of laccase-functionalized graphene oxide as an effective biodegradation of pharmaceutical industry waste: Diclofenac and ibuprofen
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
ATE332312T1 (de) Artverwandte-unabhängiger nachweis von microcystin- und nodularin-artverwandten
DE602004016838D1 (de) Verfahren zur herstellung von 4-hydroxyisoleucin und dessen derivate
WO1994025597A3 (en) METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
RU2230325C2 (ru) Способ приготовления очищенного препарата ботулинического токсина типа а
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
BR0318058A (pt) Processo para a preparação fermentativa de l-aminoácidos usando cepas da famìlia enterobacteriaceae que contêm uma sequência orf yjgf atenuada
Nagata et al. D-amino acid contents of mitochondria and some purple bacteria
Kavakcıoğlu et al. Aqueous two-phase system purification for superoxide dismutase induced by menadione from Phanerochaete chrysosporium

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]